Streetbeat News

Insider Trading

SLRX

Elvin Lee has reported a 6.09% stake in Salarius Pharmaceuticals as of October 23, 2023, according to a 13D filing with the SEC.

Portfolio Pulse from Benzinga Newsdesk

October 27, 2023 | 8:04 pm

JPM

JPMorgan Chase & Co CEO and Chairman Jamie Dimon plans to sell a part of his stake in the company starting in 2024, according to a recent filing. The filing states that Dimon and his family plan to sell one million shares for financial diversification and tax-planning purposes. This would represent around 9% of Dimon's total ownership if fully vested. The shares are worth around $137 million as of Friday. This has sparked rumors that Dimon could be looking to retire from the bank.

Portfolio Pulse from Chris Katje

October 27, 2023 | 6:27 pm

JPM

JP Morgan's CEO, Jame Dimon, and his family plan to sell 1 million shares of the company for diversification and tax-planning purposes. This news has led to a decrease in the company's share price.

Portfolio Pulse from Benzinga Newsdesk

October 27, 2023 | 4:06 pm

FSBC

SFBC

TCBI

Insider trading has been observed in three US-listed companies: Sound Financial Bancorp, Inc. (SFBC), Five Star Bancorp (FSBC), and Texas Capital Bancshares, Inc. (TCBI). SFBC's 10% owner Stilwell Partners L P acquired 2,502 shares, indicating confidence despite a decline in Q3 sales. FSBC's Director David J. Lucchetti bought 5,405 shares ahead of the company's financial results announcement. TCBI's Director Robert Stallings purchased 1,000 shares following better-than-expected quarterly results.

Portfolio Pulse from Lisa Levin

October 27, 2023 | 1:08 pm

JPM

Jamie Dimon, CEO of JPMorgan Chase (JPM), plans to sell 1 million shares of his holdings in the bank starting in 2024 for financial diversification and tax-planning purposes. This will be the first sale of stock during his tenure. Despite the planned sale, Dimon continues to express strong belief in the company's prospects. The news has led to a 0.7% drop in JPMorgan shares in premarket trading.

Portfolio Pulse from Benzinga Newsdesk

October 27, 2023 | 12:48 pm

EA

IBKR

MU

SCHW

Insiders at Charles Schwab Corporation, Micron Technology, Electronic Arts, and Interactive Brokers Group have recently sold shares. Charles Schwab reported better-than-expected Q3 earnings, Micron commenced construction on a new memory manufacturing facility, Wells Fargo maintained Electronic Arts with an Equal-Weight and raised the price target, and Interactive Brokers reported quarterly earnings beating analyst consensus.

Portfolio Pulse from Lisa Levin

October 27, 2023 | 12:44 pm

ARQT

GLT

LIFW

RGF

Insiders at four companies, The Real Good Food Company, Glatfelter Corporation, Arcutis Biotherapeutics, and MSP Recovery, have recently made significant purchases of their companies' stocks. The Real Good Food Company recently priced a public offering of its class A common stock, Glatfelter entered into a marketing agreement with Ekman & Co., Arcutis Biotherapeutics priced a $100 million public offering, and MSP Recovery announced a 1-for-25 reverse stock split.

Portfolio Pulse from Lisa Levin

October 27, 2023 | 10:43 am

LIFW

Shares of MSP Recovery, Inc. (NASDAQ:LIFW) surged after CEO John Hasan Ruiz bought 467,290 shares at an average price of $1.07 per share. The stock experienced above-average trading volume of 12.60 million shares compared to its average volume of 1.53 million. Shares of LIFW were up 33.6% at $1.44 at the time of publication.

Portfolio Pulse from Ryan Gustafson

October 26, 2023 | 7:50 pm

MSPR

MSP Recovery's CEO, John Hasan Ruiz, has purchased 467,290 shares of the company at an average price of $1.07 per share. This has led to an increase in the company's stock price.

Portfolio Pulse from Benzinga Newsdesk

October 26, 2023 | 3:57 pm

LIFW

The CEO of MSP Recovery has purchased 467,290 shares at an average price of $1.07 per share, according to a Form4 filing.

Portfolio Pulse from Benzinga Newsdesk

October 26, 2023 | 2:19 pm